請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17386完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 方啟泰(Chi-Tai Fang) | |
| dc.contributor.author | Ting-Yi Chiang | en |
| dc.contributor.author | 江亭誼 | zh_TW |
| dc.date.accessioned | 2021-06-08T00:10:05Z | - |
| dc.date.copyright | 2013-09-24 | |
| dc.date.issued | 2013 | |
| dc.date.submitted | 2013-08-08 | |
| dc.identifier.citation | Chapter 1. Background and Literature Review
1.Hill DE, Chirukandoth S, Dubey JP (2005) Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 6: 41-61. 2.Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965-1976. 3.Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39: 1385-1394. 4.Sukthana Y (2006) Toxoplasmosis: beyond animals to humans. Trends Parasitol 22: 137-142. 5.Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25: 264-296. 6.Remington JS, Klein JO (2001) Infectious diseases of the fetus and newborn infant. Philadelphia: Saunders. Xiv. 7.Siegel SE, Lunde MN, Gelderman AH, Halterman RH, Brown JA, et al. (1971) Transmission of toxoplasmosis by leukocyte transfusion. Blood 37: 388-394. 8.Derouin F, Pelloux H (2008) Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 14: 1089-1101. 9.Bowie WR, King AS, Werker DH, Isaac-Renton JL, Bell A, et al. (1997) Outbreak of toxoplasmosis associated with municipal drinking water. Lancet 350: 173-177. 10.Havelaar AH, Kemmeren JM, Kortbeek LM (2007) Disease burden of congenital toxoplasmosis. Clin Infect Dis 44: 1467-1474. 11.Dubey JP (2004) Toxoplasmosis - a waterborne zoonosis. Vet Parasitol 126: 57-72. 12.Guerina NG, Hsu HW, Meissner HC, et al (1994) Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med, 330:1858-1863. 13.Lebech M, Andersen O, Christensen NC, et al (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353:1834-1837. 14.Benard A., Salmi LR, Mouillet E, et al (2005) Systematic review on the burden of congenital toxoplasmosis in Europe. Bordeaux (France): The EUROTOXO Group 15.Benard A, Petersen E, Salamon R, Chene G, Gilbert R, Salmi LR (2008) European Toxo Prevention Study Group (EUROTOXO). Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 10; 13. pii: 18834 16.Petersen E, Vesco G, Villari S, Buffolano W. (2010) What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections? Zoonoses Public Health. 57: 8-17 17.Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, et al. (2000) Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321: 142-147. 18.Jones JL, Dargelas V, Roberts J, Press C, Remington JS, et al. (2009) Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 49: 878-884 19.Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, et al. (1999) Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis 31: 305-309. 20.Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, et al. (1996) Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol Infect 116: 347-351. 21.Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, et al. (2005) Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS 16: 302-306. 22.Ho YC, Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SC (2008) Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection. J Microbiol Immunol Infect. 41:386-92. 23.Hu IJ, Chen PC, Su FC, Hsieh CJ, Jeng SF, et al. (2006) Perinatal toxoplasmosis, northern Taiwan. Emerg Infect Dis 12: 1460-1461. 24.Lin YL, Liao YS, Liao LR, Chen FN, Kuo HM, He S (2008) Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res 103:67-74. 25.Fan CK, Liao CW, Kao TC, Lu JL, Su KE (2001) Toxoplasma gondii infection: relationship between seroprevalence and risk factors among inhabitants in two offshore islands from Taiwan. Acta Medica Okayama 55: 301-308 26.Fan CK, Su KE, Chung WC, Tsai YJ, Chiou HY, et al. (1998) Seroprevalence of Toxoplasma gondii antibodies among Atayal aboriginal people and their hunting dogs in northeastern Taiwan. Jpn J Med Sci Biol 51: 35-42. Chapter 2. Seroepidemiology of Toxoplasma gondii Infection Among Healthy Blood Donors in Taiwan 1.Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, et al. (2005) Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS 16: 302-306. 2.Yu JC (1985) [A seroepidemiological study on Toxoplasma gondii infection among pregnant women and neonates in Taiwan]. Taiwan Yi Xue Hui Za Zhi 84: 286-295. 3.Hu IJ, Chen PC, Su FC, Hsieh CJ, Jeng SF, et al. (2006) Perinatal toxoplasmosis, northern Taiwan. Emerg Infect Dis 12: 1460-1461. 4.Fan CK, Su KE, Chung WC, Tsai YJ, Chiou HY, et al. (1998) Seroprevalence of Toxoplasma gondii antibodies among Atayal aboriginal people and their hunting dogs in northeastern Taiwan. Jpn J Med Sci Biol 51: 35-42. 5.Fan CK, Su KE, Wu GH, Chiou HY (2002) Seroepidemiology of Toxoplasma gondii infection among two mountain aboriginal populations and Southeast Asian laborers in Taiwan. J Parasitol 88: 411-414. 6.Edvinsson B, Lappalainen M, Evengard B (2006) Real-time PCR targeting a 529-bp repeat element for diagnosis of toxoplasmosis. Clin Microbiol Infect 12: 131-136. 7.Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, et al. (2000) Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321: 142-147. 8.Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, et al. (1999) Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis 31: 305-309. 9.Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, et al. (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154: 357- 365. 10.Jones JL, Dargelas V, Roberts J, Press C, Remington JS, et al. (2009) Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 49: 878-884. 11.Alvarado-Esquivel C, Mercado-Suarez MF, Rodriguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, et al. (2007) Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis 7: 75. 12.Pinlaor S, Ieamviteevanich K, Pinlaor P, Maleewong W, Pipitgool V (2000) Seroprevalence of specific total immunoglobulin (Ig), IgG and IgM antibodies to Toxoplasma gondii in blood donors from Loei Province, Northeast Thailand. Southeast Asian J Trop Med Public Health 31: 123-127. 13.Sukthana. Y, Chintana. T, Supathanapong. W, Siripanth. C, Lekkla. A, et al. (2000) Prevalence of toxoplasmosis in selected populations in Thailand. J Trop Med Parasitol 23: 53-58. 14.Coelho RA, Kobayashi M, Carvalho LB, Jr. (2003) Prevalence of IgG antibodies specific to Toxoplasma gondii among blood donors in Recife, Northeast Brazil. Rev Inst Med Trop Sao Paulo 45: 229-231. 15.Zamorano CG, Contreras MC, Villalobos S, Sandoval L, Salinas P (1999) [Seroepidemiological survey of human toxoplasmosis in Osorno, Region X, Chile, 1998]. Bol Chil Parasitol 54: 33-36. 16.Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, et al. (2002) Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia 57: 304-310. 17.Elhence P, Agarwal P, Prasad KN, Chaudhary RK (2010) Seroprevalence of Toxoplasma gondii antibodies in North Indian blood donors: implications for transfusion transmissible toxoplasmosis. Transfus Apher Sci 43: 37-40. 18.Elsheikha HM, Azab MS, Abousamra NK, Rahbar MH, Elghannam DM, et al. (2009) Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitol Res 104: 1471-1476. 19.Svobodova V, Literak I (1998) Prevalence of IgM and IgG antibodies to Toxoplasma gondii in blood donors in the Czech Republic. Eur J Epidemiol 14: 803-805. 20.Zarkovic A, McMurray C, Deva N, Ghosh S, Whitley D, et al. (2007) Seropositivity rates for Bartonella henselae, Toxocara canis and Toxoplasma gondii in New Zealand blood donors. Clin Experiment Ophthalmol 35: 131-134. 21.Chiang TY, Ji DD (2011) Epidemics of toxoplasmosis in Taiwan. Taiwan Epidemiol Bull 27: 353-360. 22.Lindsay DS, Dubey JP (2009) Long-term survival of Toxoplasma gondii sporulated oocysts in seawater. J Parasitol 95: 1019-1020. 23.Esmerini PO, Gennari SM, Pena HF (2010) Analysis of marine bivalve shellfish from the fish market in Santos city, Sao Paulo state, Brazil, for Toxoplasma gondii. Vet Parasitol 170: 8-13. 24.Miller MA, Miller WA, Conrad PA, James ER, Melli AC, et al. (2008) Type X Toxoplasma gondii in a wild mussel and terrestrial carnivores from coastal California: new linkages between terrestrial mammals, runoff and toxoplasmosis of sea otters. Int J Parasitol 38: 1319-1328. 25.Putignani L, Mancinelli L, Del Chierico F, Menichella D, Adlerstein D, et al. (2011) Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG). Exp Parasitol 127: 409-417. 26.Dubey JP (2004) Toxoplasmosis - a waterborne zoonosis. Vet Parasitol 126: 57-72. 27.Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965-1976. 28.Derouin F, Pelloux H (2008) Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 14: 1089-1101. 29.Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J (2007) New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin Microbiol Infect 13: 1012-1017. Chapter 3. Risk Factors for Acute Toxoplasmosis in Taiwan: a Population-based Case- Control Study 1.Chiang TY, Hsieh HH, Kuo MC, Chiu KT, Lin WC, Fan CK, Fang CT, Ji DD. (2012). Seroepidemiology of Toxoplasma gondii Infection among Healthy Blood Donors in Taiwan. PLoS ONE 7: e48139. 2.Centers for Disease Control, Department of Health, R.O.C. (2010) Guidelines for Notifiable Communicable Diseases Surveillance (2E). Http://www.cdc.gov.tw/english/infectionreportinfo.aspx?treeid=3847719104be0678&nowtreeid=3112320c3b647165&tid=10D0E6D1DA6BB77D. 3.Edvinsson B, Lappalainen M, Evengard B (2006) Real-time PCR targeting a 529-bp repeat element for diagnosis of toxoplasmosis. Clin Microbiol Infect 12: 131-136. 4.Frenkel JK, Dubey JP, Miller NL (1970) Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science 167:893- 896. 5.Dubey JP, Frenkel JK (1972) Cyst-induced toxoplasmosis in cats. J. Protozool. 19: 155-177. 6.Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, et al. (1999) Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis 31: 305-309. 7.Alvarado-Esquivel C, Mercado-Suarez MF, Rodriguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, et al. (2007) Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis 7: 75-81 8.Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J (2007) New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin Microbiol Infect 13: 1012-1017. 9.Lin YL, Liao YS, Liao LR, Chen FN, Kuo HM, et al. (2008) Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res 103: 67-74. 10.Dattoli VC, Veiga RV, Cunha SS, Pontes-de-Carvalho L, Barreto ML, et al. (2011) Oocyst ingestion as an important transmission route of Toxoplasma gondii in Brazilian urban children. J Parasitol 97: 1080-1084. 11.Zemene E, Yewhalaw D, Abera S, Belay T, Samuel A, et al. (2012) Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia. BMC Infect Dis 12: 337-342. 12.Walle F, Kebede N, Tsegaye A, Kassa T (2013) Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia. Parasit Vectors 6: 15-22 13.Jones JL, Dargelas V, Roberts J, Press C, Remington JS, et al. (2009) Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 49: 878-884. 14.Putignani L, Mancinelli L, Del Chierico F, Menichella D, Adlerstein D, et al. (2011) Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG). Exp Parasitol 127: 409-417. 15.Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19. 16.Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, et al. (2000) Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321: 142-147. 17.Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, et al. (1996) Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol Infect 116: 347-351. 18.Fan CK, Su KE, Chung WC, Tsai YJ, Chiou HY, et al. (1998) Seroprevalence of Toxoplasma gondii antibodies among Atayal aboriginal people and their hunting dogs in northeastern Taiwan. Jpn J Med Sci Biol 51: 35-42. 19.Fan CK, Su KE, Wu GH, Chiou HY (2002) Seroepidemiology of Toxoplasma gondii infection among two mountain aboriginal populations and Southeast Asian laborers in Taiwan. J Parasitol 88: 411-414. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17386 | - |
| dc.description.abstract | 弓形蟲 (Toxoplasma gondii) 是一種胞內寄生原蟲,為人畜共通傳染病病原體。弓形蟲感染症於2007年納入第四類法定傳染病,但其在台灣一般人群的流行病學仍不明。過去文獻侷限於特殊族群血清學調查及零星病例報告,缺乏全國性弓形蟲感染盛行率及感染途徑調查。本研究與全台灣6區的捐血中心合作,蒐集1,783位捐血人之血液、血清檢體進行弓形蟲即時聚合酶鏈鎖反應與酵素免疫分析法篩檢,同時蒐集捐血人暴露因子及人口學資訊,分析與感染弓形蟲相關性。研究結果發現弓形蟲感染普遍存在於全台各地,整體血清抗體陽性率9.3% (其中5人為anti-Toxoplasma IgM陽性,但輔以親和力試驗確認仍為非急性期感染),東部顯著較高 (18.8%)。多變項邏輯斯迴歸分析顯示居住東部、低教育程度、生食豬肉、生食貝類、家中豢養貓等為台灣地區民眾感染弓形蟲可能相關因子。進一步以病例對照研究加以探究,以法定傳染病通報系統的急性感染個案做為病例組 (n=30),以1:8比例依年齡、性別、地區自血清陰性捐血人隨機樣本中,配對選取對照組 (n=224),以檢驗可能的危險因子。 30位急性感染病人中,臨床病徵多以類流感症狀併淋巴結腫大或硬塊表現,其次為中樞神經系統症狀,眼部病徵,流產,及先天性感染。多變項邏輯斯迴歸分析發現:生食文蛤 (adjusted OR=3.7 , 95%CI: 1.4–9.9)、家中豢養貓 (adjusted OR=2.9, 95%CI: 1.1–7.9) 為台灣地區急性弓形蟲疾病的獨立危險因子。本研究為台灣首次全國性大規模弓形蟲流行病學調查,提供感染盛行率、感染途徑及發病危險因子實證資料,可做為未來制定弓形蟲防治政策的參考。 | zh_TW |
| dc.description.abstract | Toxoplasma gondii, an intracellular protozoan pathogen, causes human and animal diseases worldwide. Although toxoplasmosis became a notifiable communicable disease in Taiwan in 2007, little is known about its epidemiology among the general population. Through collaborating with the Taiwan Blood Services Foundation, a total of 1,783 healthy blood donors from all six-branch blood service centers participated in our study. Of the 1,783 participants, 166 (9.3%) tested positive for anti-Toxoplasma IgG, while 5 (0.28%) tested positive for anti-Toxoplasma IgM. The five IgM positive donors had high avidity antibodies suggestive of past infection. No active parasitemia was detected by real-time PCR assays. Multivariate logistic regression showed that undercooked pork meat consumption, raw mussels consumption, having a cat in the household, a lower education level, and donation place in eastern Taiwan were associated with Toxoplasma seropositivity. We further conducted a nationwide population-based case-control study aimed to investigate the risk factors for acute Toxoplasma gondii disease in Taiwan. Cases of acute human toxoplasmosis notified to Taiwan Centers for Diseases Control were compared with controls randomly selected from healthy T. gondii-seronegative blood donors. Cases and controls were matched on age, gender and residency, at a ratio of 1:8. A total of 30 laboratory-confirmed cases of acute toxoplasmosis and 224 controls were enrolled. The most common clinical manifestation of toxoplasmosis cases was flu-like symptoms (n=20), followed by central nervous system disease (n=4), ocular diseases (n=3), abortion (n=2), and congenital infection (n=1). Multivariate conditional logistic regression showed that consumption of raw clam (adjusted odds ratio [OR] = 3.7; 95%CI: 1.4–9.9) and having a cat in the household (adjusted OR = 2.9; 95%CI: 1.1–7.9) were the two independent risk factors for acute toxoplasmosis. These findings can guide future research and control policy. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T00:10:05Z (GMT). No. of bitstreams: 1 ntu-102-D96842003-1.pdf: 1067213 bytes, checksum: 2b954c26da503b1b9e23650d4daf3fa0 (MD5) Previous issue date: 2013 | en |
| dc.description.tableofcontents | Contents
中文摘要 i Abstract ii List of Tables vii List of Figures ix Chapter 1. Background and Literature Review 1 References 5 Chapter 2. Seroepidemiology of Toxoplasma gondii infection among healthy blood donors in Taiwan 9 2.1 Objective 9 2.2 Materials and Methods 9 Study design 9 Participants 10 Ethics 10 Serologic testing 10 Real-time polymerase chain reaction (PCR) 11 Questionnaire 12 Statistical analysis 12 2.3 Results 12 Participants 12 Seroprevalence of anti-T. gondii antibodies 13 Real time PCR 13 Risk factors of being anti-T gondii IgG-seropositive 14 2.4 Discussion 14 2.5 References 19 Chapter 3. Risk Factors for Acute Toxoplasmosis in Taiwan: a Population-based Case- Control Study 23 3.1 Objective 23 3.2 Materials and Methods 23 Study Design 23 Ethical Statement 24 Setting 24 Case Definition 24 Serological Diagnosis of Acute Toxoplasmosis 25 Real-time PCR Diagnosis of Acute Toxoplasmosis 25 Control Selection 26 Study Questionnaire 26 Information on HIV Infection 27 Statistical Analysis 27 3.3 Results 28 Cases 28 Controls 29 Clinical Manifestations of Acute Toxoplasmosis 29 Risk Factors for Acute Toxoplasmosis 30 3.4 Discussion 30 3.5 References 35 Chapter 4. Conclusion and Future Perspectives 38 Appendix 1. Questionnaire 60 Appendix 2. Included vs declined cases 61 | |
| dc.language.iso | en | |
| dc.title | 臺灣地區弓形蟲感染症之流行病學研究 | zh_TW |
| dc.title | Epidemiology of Toxoplasmosis in Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 101-2 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 陳國東,郭柏秀,嵇達德,施惟量 | |
| dc.subject.keyword | 弓形蟲感染症,危險因子, | zh_TW |
| dc.subject.keyword | Toxoplasmosis,risk factor, | en |
| dc.relation.page | 61 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2013-08-08 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-102-1.pdf 未授權公開取用 | 1.04 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
